Vol. I · No. 33
Thursday, August 13, 2026
Issue: Summer · 2026
Established · MMXXVI
— The evidence base for longevity medicine —
Indexed by PubMed · CTG · Cochrane
Editorial team · geroevidence.com
Subscription · app.geroevidence.com
Geroevidence · Editorial desk · Evidence Analysis

Evidence Analysis

How to read the evidence — study design, bias, and interpretation.

18 articles in this category · ← All categories
§ Evidence Analysis · 18 articles · page 2 of 2
Berberine vs. metformin: is "nature's Ozempic" backed by longevity evidence?
Berberine has been called "nature's Ozempic" online. Here is how its actual human trial evidence compares to metformin's.
June 24, 2026  ·  10 min read
Dasatinib + quercetin vs. fisetin: comparing the senolytic evidence
A direct comparison of the two leading senolytic approaches — mechanism, current human trial data, and evidence strength, rated honestly.
June 23, 2026  ·  11 min read
NMN vs NR: comparing the evidence for the two main NAD+ precursors
A direct head-to-head comparison of every published human trial for NMN and NR — evidence rated honestly, and what the first head-to-head trial will tell us.
May 8, 2026  ·  9 min read
← Newer
Page 2 of 2